The Ohio biotechnology firm Optimvia Pharmaceuticals says it has developed a cost-effective synthetic method to produce large quantities of heparin,...
Read moreCapitalize Financial, a news portal which provides the financial news global wide.
© 2021 Capitalize Financial All Rights Reserved